Yeji

$ANIP

ANI PHARMACEUTICALS INC

Runway:cash-flow +
NasdaqMarket cap: —CIK 0001023024

Upcoming catalysts

0 surfaced

No catalysts surfaced for ANIP yet.

Drug pipeline

carboprost tromethamine
baclofen
memantine and donepezil hydrochlorides
colestipol hydrochloride
nitazoxanide
fesoterodine fumarate
iluvien
chronic non-infectious uveitis affecting the posterior segment of the eye

Recent catalysts

FDA approvalMar 14, 2025· 449d ago
$ANIPANI PHARMACEUTICALS INC
iluvien · chronic non-infectious uveitis affecting the posterior segment of the eye
“the U.S. Food and Drug Administration has approved an expanded label for ILUVIEN ® (fluocinolone acetonide intravitreal implant) that includes an indication for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye”
FDA approvalFeb 3, 2025· 488d ago· success
$ANIPANI PHARMACEUTICALS INC
nitazoxanide
“openFDA ORIG (UNKNOWN) approval of NITAZOXANIDE — application ANDA214844”
FDA approvalJan 25, 2024· 863d ago· success
$ANIPANI PHARMACEUTICALS INC
carboprost tromethamine
“openFDA ORIG (UNKNOWN) approval of CARBOPROST TROMETHAMINE — application ANDA215901”
FDA approvalDec 15, 2023· 904d ago· success
$ANIPANI PHARMACEUTICALS INC
memantine and donepezil hydrochlorides
“openFDA ORIG (UNKNOWN) approval of MEMANTINE AND DONEPEZIL HYDROCHLORIDES — application ANDA208237”
FDA approvalJun 8, 2023· 1094d ago· success
$ANIPANI PHARMACEUTICALS INC
baclofen
“openFDA ORIG (UNKNOWN) approval of BACLOFEN — application ANDA217252”
FDA approvalMar 10, 2023· 1184d ago· success
$ANIPANI PHARMACEUTICALS INC
colestipol hydrochloride
“openFDA ORIG (UNKNOWN) approval of COLESTIPOL HYDROCHLORIDE — application ANDA216517”
FDA approvalJan 4, 2023· 1249d ago· success
$ANIPANI PHARMACEUTICALS INC
fesoterodine fumarate
“openFDA ORIG (UNKNOWN) approval of FESOTERODINE FUMARATE — application ANDA204504”